Grayken Center for Addiction
Affirming that Recovery is Possible
Affirming that Recovery is Possible
The Grayken Center for Addiction at Boston Medical Center is a national hub for substance use disorder resources. Through more than a dozen treatment and support programs, here at Grayken we revolutionize addiction treatment and education, replicate best practices, and provide policy, advocacy and thought leadership.
At Boston Medical Center, we recognize that one size doesn’t fit all when it comes to addiction treatment. BMC has developed tailored treatment programs that meet patients where they are, be it in an office or on the street. All of our programs emphasize evidence-based treatments. Click here to learn more about our programs!
Substance Use Disorder Research
Research is a core focus area for the Grayken Center. From finding new and better treatments for infants with neonatal abstinence syndrome to conducting research while caring for patients to investigating how to minimize harm from chronic opioid use for pain management, BMC research is helping to shine light on how to best care for patients with addiction.
Residency and Fellowship Information
BMC has a number of unique opportunities for residents and fellows to train in caring for patients with addiction, including an addiction medicine fellowship program, addiction psychiatry fellowship program, and addiction training in the general psychiatry residency. These programs all train clinicians in different stages of their career in the recognition, diagnosis, and treatment of substance use disorders in a variety of settings.
Grayken Center Employer Resource Library
The Grayken Center for Addiction at Boston Medical Center (BMC) has designed a set of tools and resources to support your organization in understanding and addressing substance use disorders (SUDs). These tools are free to use, regardless of where or how your organization receives its medical care.
Grayken Center News
Information from leaders in the addiction field to help fight stigma and create awareness of current issues facing providers and patients today.
Latest from HealthCity
After one year, the Ottawa-based program's retention was 77%. Now, experts are looking at how it could inform opioid addiction treatment in the U.S.
Grayken Center for Addiction staff testified to the state on the need for safe consumption sites to address opioid overdose deaths.
Many nursing schools lack addiction care in the curriculum. Now, Boston Medical Center nurses are working to fill that education gap.
Despite advice from medical groups, nearly two-thirds of patients studied didn't receive medication for opioid use disorder.
HEALing Communities Study data underscores the need for racially inclusive approaches to address the opioid epidemic in vulnerable neighborhoods.
A new clinical trial will research how BRIGHT, a trauma-responsive, attachment-based therapeutic parenting intervention, helps mothers with addiction.
The HEALing Communities Study is up and running in several cities, bringing opioid use disorder treatment to people where they are.
BMC experts testified in support of eliminating the requirement to report abuse and neglect for babies born with neonatal opioid withdrawal syndrome.
After being in treatment during pregnancy, 40% of women relapse within the first year of their baby’s life. Experts advocate for extended support.
Miriam Komaromy, director of BMC's Grayken Center for Addiction cautions that the new rules don't go far enough in addressing opioid overdose deaths.
A study reveals that people at a drug detoxification site were unaware of HIV pre-exposure prophylaxis, or PrEP, but were enthusiastic when informed.
Many providers feel ill-equipped to treat substance use disorder with medications, like other other chronic disease. A new tool from BMC may help.